levodopa has been researched along with stalevo in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (57.69) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hauser, RA | 1 |
| Guarnieri, M; Hubble, J; Koller, W; Rabinowicz, AL; Silver, D | 1 |
| Silver, DE | 1 |
| Agid, Y; Brooks, DJ; Eggert, K; Holopainen, A; Ostergaard, K; Widner, H | 1 |
| Apajasalo, M; Findley, LJ; Lees, A; Pitkänen, A; Turunen, H | 1 |
| Haapaniemi, T; Hartikainen, P; Heikkinen, H; Jolma, T; Kaakkola, S; Kinnunen, E; Kuopio, AM; Myllylä, V; Nuutinen, J; Rissanen, A; Satomaa, O | 1 |
| Fedorova, NV; Kulua, TK; Levin, OS; Smolentseva, IG | 1 |
| Hernández, B; Kulisevsky, J; Linazasoro, G | 1 |
| Klivényi, P; Vécsei, L | 2 |
| Babina, LA; Batysheva, TT; Boĭko, AN; Khozova, AA; Kostenko, EV; Malykhina, EA; Minaeva, NG; Shikhkerimov, RK; Vdovichenko, TV; Zaĭtsev, KA; Zhuravleva, EIu | 1 |
| Chigir', IP; Dokadina, LV; Fedorova, NV; Levin, OS; Makhnev, SO; Smolentseva, IG | 1 |
| Babina, LA; Batysheva, TT; Boiko, AN; Khozova, AA; Kostenko, EV; Malykhina, EA; Minaeva, NG; Shikhkerimov, RK; Vdovichenko, TV; Zaitsev, KA; Zhuravleva, EY | 1 |
| Litvinenko, IV; Mogil'naia, VI; Odinak, MM; Sakharovskaia, AA; Sologub, OS | 1 |
| Bokor, M; Szentesi, A | 1 |
| Barba, E; Bugamelli, F; Marcheselli, C; Raggi, MA | 1 |
| Bogdanov, RR; Kotov, SV; Kunitsyna, AN; Turbina, LG | 1 |
| Ivanov, AK; Levin, OS; Shindriaeva, NN | 1 |
| Fedorova, NV; Kulua, TK; Popovkina, OA | 1 |
| Fedotova, EIu; Illarioshkin, SN; Ivanova-Smolenskaia, IA; Karabanov, AV; Mirkasimov, AF; Poleshchuk, VV; Polevaia, EV; Zagorovskaia, TB | 1 |
| Sheehan, J; Thorpe, M; Wilson, L | 1 |
| Levin, OS; Liashchenko, EA; Skripkina, NA | 1 |
| Fedorova, NV; Kulua, TK | 1 |
| Kretova, AS; Lyubimov, AV | 1 |
| Gupta, S; Hsu, A; Modi, NB; Yao, HM | 1 |
2 review(s) available for levodopa and stalevo
| Article | Year |
|---|---|
Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
Topics: Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Nitriles; Parkinson Disease | 2004 |
[Influence of levodopa, stalevo on dyskinesia in Parkinson's disease: STRIDE-PD study].
Topics: Antiparkinson Agents; Carbidopa; Catechols; Corpus Striatum; Drug Combinations; Drug Therapy, Combination; Dyskinesias; Humans; Levodopa; Parkinson Disease; Treatment Outcome | 2013 |
15 trial(s) available for levodopa and stalevo
| Article | Year |
|---|---|
Levodopa/carbidopa/entacapone (Stalevo).
Topics: Aged; Antiparkinson Agents; Area Under Curve; Biological Availability; Carbidopa; Catechols; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Evaluation; Female; Headache; Humans; Levodopa; Male; Middle Aged; Nausea; Nitriles; Reference Values; Therapeutic Equivalency | 2004 |
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
Topics: Adult; Aged; Carbidopa; Catechols; Drug Combinations; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 2005 |
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Disability Evaluation; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Activity; Nitriles; Pain Measurement; Parkinson Disease; Quality of Life; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome | 2005 |
Patient satisfaction with switching to Stalevo: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study).
Topics: Adult; Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Catechols; Cross-Over Studies; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Patient Satisfaction; Treatment Outcome | 2006 |
[Stalevo (levodopa/carbidopa/entacapon)--a new generation drug in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2006 |
Should levodopa dose be reduced when switched to stalevo?
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2008 |
[The study on the assessment of the new levodopa drug--stalevo (levodopa/carbidopa/entacapone), in treatment of Parkinson's disease in out-patient clinical practice (the results of the open START-M)].
Topics: Activities of Daily Living; Aged; Ambulatory Care Facilities; Carbidopa; Catechols; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Outpatients; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
[The clinical-pharmacoeconomic study of efficacy of stalevo in the treatment of Parkinson's disease with motor fluctuations].
Topics: Antiparkinson Agents; Carbidopa; Catechols; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Disorders; Severity of Illness Index | 2008 |
Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Outpatients; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome | 2008 |
[Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Treatment Outcome | 2009 |
[Pharmacotherapy of motor manifestations in late stages of Parkinson's disease].
Topics: Aged; Carbidopa; Catechols; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2010 |
[Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone].
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sleep Disorders, Intrinsic | 2011 |
[Nocturnal symptoms of Parkinson's disease and approaches to their correction].
Topics: Carbidopa; Catechols; Drug Combinations; Dyskinesias; Humans; Levodopa; Muscle Cramp; Nocturia; Parkinson Disease; Restless Legs Syndrome | 2013 |
[The use of stalevo in the treatment of patients with Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2014 |
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapo
Topics: Adolescent; Adult; Antiparkinson Agents; Carbidopa; Catechols; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Young Adult | 2015 |
9 other study(ies) available for levodopa and stalevo
| Article | Year |
|---|---|
Stalevo for Parkinson's disease.
Topics: Carbidopa; Catechols; Diarrhea; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Nausea; Nitriles; Parkinson Disease | 2004 |
Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Carbidopa; Catechols; Child; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Female; Humans; Levodopa; Male; Markov Chains; Middle Aged; Parkinson Disease; United Kingdom | 2005 |
[The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Carbidopa; Catechols; Cholinergic Antagonists; Dopamine Agonists; Drug Combinations; Female; Humans; Hungary; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Selegiline; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2008 |
[Long term experience with Stalevo in Szeged, Hungary].
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Combinations; Drug Resistance; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Pain Measurement; Parkinson Disease; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
[The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off].
Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Drug Administration Schedule; Drug Combinations; Female; Humans; Hungary; Levodopa; Male; Middle Aged; Observation; Parkinson Disease; Quality of Life; Treatment Outcome | 2010 |
Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
Topics: Antiparkinson Agents; Calibration; Carbidopa; Catechols; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Levodopa; Methyldopa; Nitriles; Reproducibility of Results; Solid Phase Extraction | 2011 |
[Treatment of non-motor fluctuations with combined drug stalevo in patients with Parkinson's disease].
Topics: Adult; Aged; Carbidopa; Catechols; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome | 2011 |
[A combined preparation stalevo in Parkinson's disease: a 5-year experience of continuous dopaminergic stimulation].
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Catechols; Dopamine Agonists; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome | 2012 |
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline | 2013 |